Acute myeloid leukemia (AML) also known as acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia, and acute non-lymphocytic leukemia is a cancer that starts in the bone marrow (the soft inner part of certain bones, where new blood cells are made), moving often into...
Acute myeloid leukemiaTargeted therapyFLT3 inhibitorsBCL2 inhibitorsIDH inhibitorsHypomethylating agentsThe extensive genomic characterization of acute myeloid leukemia (AML) led to the identification of a vast number of potential therapeutic targets. We review relevant data that have led to recent approval...
Larson ML, Venugopal P. Clofarabine: a new treatment option for patients with acute myeloid leukemia. Expert Opin Pharmacother. 2009;10(8):1353-7.Larson ML, Venugopal P. Clofarabine: a new treatment option for patients with acute myeloid leukemia. Expert Opin Pharmacother. 2009; 10 (8): ...
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow It occurs when the bone marrow, which is responsible for producing blood cells, starts making too many abnormal white blood cells called myeloblasts.
Acute myeloid leukemia (AML) is a type of blood cancer.Learn about this cancer that forms in the bone and bone marrow. Treatments include medications and bone marrow transplant.
Find all the latest on acute myeloid leukemia at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
and division. Sometimes these enzymes can be overactive, which helps cancer cells survive and multiply. A tyrosine kinase inhibitor (TKI) is a medication given to certain acute myeloid leukemia (AML) patients to block the actions of overactive tyrosine kinases, with the ultimate goal of stopping...
This 45-page report provides a behind-the-scenes look at the treatment experience for those living with acute myeloid leukemia (AML). Using detailed quantitative data, it gives a full picture of the AML treatment story - from HCP conversations to tr...
Geoffrey Uy, MD, assistant professor of medicine, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine, Siteman Cancer Center, discusses therapy selection in acute myeloid leukemia (AML). It is becoming increasingly complex to select the appropriate ...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell transplantation (alloHSCT), this effect has been ...